These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28507865)

  • 1. Reconstitution of Human Keloids in Mouse Skin.
    Sunaga A; Kamochi H; Sarukawa S; Uda H; Sugawara Y; Asahi R; Chi D; Nakagawa S; Kanayama K; Yoshimura K
    Plast Reconstr Surg Glob Open; 2017 Apr; 5(4):e1304. PubMed ID: 28507865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic and keloid scars fail to progress from the CD34
    Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model of humanised keloid scarring in mice.
    Shang T; Yao B; Gao D; Xie J; Fu X; Huang S
    Int Wound J; 2018 Feb; 15(1):90-94. PubMed ID: 29076632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of actin and myosin in the scar tissue].
    Zhang Q; Qian YL; Cui L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstructed human keloid models show heterogeneity within keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
    Li W; Cen Y; Wang H; Chen W; Liu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
    Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
    Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
    Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
    J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The distrubution of cell cycle on fibrolasts derived from the pathlogical scars and analysis of Fas gene mutations in keloids using polymerse chain Reaction-based single-strand conformation polymorphism].
    Lu F; Gao j ; Li X
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):709-12. PubMed ID: 11798842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings.
    Huang C; Akaishi S; Hyakusoku H; Ogawa R
    Int Wound J; 2014 Oct; 11(5):517-22. PubMed ID: 23173565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.
    Limandjaja GC; Niessen FB; Scheper RJ; Gibbs S
    Front Cell Dev Biol; 2020; 8():360. PubMed ID: 32528951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Austin E; Koo E; Jagdeo J
    Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell-derived endothelin-1 is involved in abnormal scar formation by dermal fibroblasts through RhoA/Rho-kinase pathway.
    Kiya K; Kubo T; Kawai K; Matsuzaki S; Maeda D; Fujiwara T; Nishibayashi A; Kanazawa S; Yano K; Amano G; Katayama T; Hosokawa K
    Exp Dermatol; 2017 Aug; 26(8):705-712. PubMed ID: 27892645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the basement membrane zone differs between keloids, hypertrophic scars and normal skin: a possible background to an impaired function.
    Hellström M; Hellström S; Engström-Laurent A; Bertheim U
    J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1564-72. PubMed ID: 25037500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal Models for Studies of Keloid Scarring.
    Supp DM
    Adv Wound Care (New Rochelle); 2019 Feb; 8(2):77-89. PubMed ID: 31832272
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrastructural differentiation of abnormal scars.
    Meenakshi J; Jayaraman V; Ramakrishnan KM; Babu M
    Ann Burns Fire Disasters; 2005 Jun; 18(2):83-8. PubMed ID: 21990984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.